CSE/WBIO (CSE/WBIO)

Canadian Securities Exchange: CSE/WBIO · CAD

CA$0.07

+0.00 (0.0%)· Recorded snapshot

Market cap	324.8K
Net income (ttm)	-6.7K
EPS (ttm)	-CA$0.00
Shares out	4.6M
Volume	8,000
Beta	-0.10

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -6.7K
EPS (ttm): -CA$0.00
Market cap: 324.8K

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/En/a

P25 9.9P50 23.3P75 38.5

ROEn/a

P25 -104.1P50 -30P75 6.7

ROICn/a

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

All CSE/WBIO indicators

Market & fundamental data

Available fields

115

Groups with data

Currency

CAD

Showing 115 of 115 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-12-11
Employees	16
Employees change	-7
Employees growth	-30.43%
Enterprise value	CAD 706,303
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2024-09-30
First seen	2026-05-10
Fiscal year end	December
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CA92941F2044
Last earnings date	2025-12-12
Last refreshed	2026-10-29
Last stock split date	2024-12-30
Last stock split type	Reverse
Market cap	CAD 324,763
Next earnings date	2026-12-11
Price	CAD 0.07
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2025-05-08
Symbol	cse/WBIO
Website	https://www.wpdpharmaceuticals.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-2.1%
FCF / EV yield	-24.35%
FCF yield	-52.96%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	CAD -419
ROA	-71.58%
ROA (5Y)	-127.29%
ROCE	115.14%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
Net income growth quarters	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	CAD 4,941
EBIT	CAD -290,036
EBITDA	CAD -285,095
EPS	CAD -0.00
FCF per share	CAD -0.04
Financing cash flow	CAD 30,500
Free cash flow	CAD -171,987
Investing cash flow	CAD 7,368
Net borrowing	CAD -2,335
Net cash flow	CAD -134,119
Net income	CAD -6,706
Operating income	CAD -290,036

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CAD -0.13
Interest coverage	-4.93
Long-term assets	CAD 235,534
Long-term liabilities	CAD 370,380
Net cash (debt)	CAD -381,541
Net cash / market cap	-117.48%
Piotroski F-Score	0
Shareholders' equity	CAD -622,289
Tangible book value	CAD -622,289
Tangible book value per share	CAD -0.13
Total assets	CAD 292,535
Total cash	CAD 9,339
Total debt	CAD 390,880
Total liabilities	CAD 914,824
WACC	8.18%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 57,001
Current liabilities	CAD 544,444
Current ratio	0.1
Net working capital	CAD -476,282
Quick ratio	0.1
Working capital	CAD -487,443

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.57%
Shareholder yield	-0.57%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	0%
20-day SMA	CAD 0.15
3M price change	-63.16%
3M total return	-63.16%
52-week high	CAD 1.13
52-week high date	2024-05-24
52-week low	CAD 0.07
52-week low date	2025-05-08
6M price change	-44%
6M total return	-44%
All-time high	CAD 1.13
All-time high date	2024-05-24
All-time low	CAD 0.07
All-time low date	2025-02-20
Average true range (ATR)	CAD 0.06
Average volume	3.5K
Beta (1Y)	0
Beta (2Y)	0.04
Beta (5Y)	-0.1
Change from 52-week high	-93.78%
Change from 52-week low	0%
Change from all-time high	-93.78%
Change from all-time low	0%
Change from open	0%
Day's gap	0%
Dollar volume	CAD 560
High price	CAD 0.07
Low price	CAD 0.07
Monthly RSI	0
Open price	CAD 0.07
Previous close	CAD 0.07
Price vs 20-day SMA	-53.83%
Relative volume	2.28
RSI	39.2
Sharpe ratio	1.65
Sortino ratio	4.54
Volume	8K
Weekly RSI	5.29
YTD price change	-41.67%
YTD total return	-41.67%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares change (QoQ)	1.65%
Shares outstanding	4.6M

Deeper analysis on CSE/WBIO

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/WBIO report

Is a complete CSE/WBIO research report available?

No complete published report is available for cse/WBIO (CSE/WBIO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/WBIO (CSE/WBIO)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/WBIO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/WBIO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/WBIO

Frequently asked questions